A 5 p.m. EST call will cover LeMaitre's results on Nov. 4
LeMaitre Vascular (Nasdaq:LMAT) will release Q3 2026 financial results on Nov. 4 after market close, followed by a conference call at 5:00 PM EST to discuss results, business highlights, and company outlook. The call is accessible via registration and will also be available as an audio webcast.
How this was made
The 30-second read
Why it matters
This sets a defined earnings catalyst window for LMAT, which can drive pre-earnings positioning and after-close volatility once results are released.
Market read
The main tradable element is the confirmed earnings date and call time, which helps traders plan risk around the upcoming print.
What to watch
Traders may still react if the call agenda or outlook language differs from expectations, but that information is not included here.
Background
LeMaitre Vascular is a peripheral vascular disease device company that will report Q3 2026 results on Nov. 4 after the market close.
Ticker impact
LeMaitre schedules its Q3 2026 results for Nov. 4 after the close, with a 5:00 PM ET call to discuss outlook.
Likely volatility around the after-close earnings release and the 5:00 PM ET commentary as traders price the upcoming quarter and guidance.
The article is a scheduled earnings announcement without any new financial figures, but it sets a concrete catalyst date and timing for LMAT.
Market effects
Limited sector read-through because it is only a scheduling notice, not results or guidance.
Minimal, as it is a single-company event with no macro policy content.
Low, since the news is company-specific and not tied to global regulatory or supply shocks.
Counterpoint
Because no numbers or guidance are provided, the announcement may have little incremental impact beyond confirming the calendar.
Key entities
- companyLeMaitre Vascular, Inc.
Nasdaq-listed medical device company releasing Q3 2026 results on Nov. 4 and holding a 5:00 PM ET call.
